BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 29979498)

  • 1. [The progress of novel drug delivery systems].
    Gao HL; Jiang XG
    Yao Xue Xue Bao; 2017 Feb; 52(2):181-8. PubMed ID: 29979498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of novel core-shell dual-mesoporous silica nanoparticles for the production of high bioavailable controlled-release fenofibrate tablets.
    Zhao Z; Gao Y; Wu C; Hao Y; Zhao Y; Xu J
    Drug Dev Ind Pharm; 2016; 42(2):199-208. PubMed ID: 26114553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and Evaluation of Hydrophilic Matrix System Containing Polyethylene Oxides for the Zero-Order Controlled Delivery of Water-Insoluble Drugs.
    Wang L; Chen K; Wen H; Ouyang D; Li X; Gao Y; Pan W; Yang X
    AAPS PharmSciTech; 2017 Jan; 18(1):82-92. PubMed ID: 26883263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel asymmetric membrane osmotic pump capsule with in situ formed delivery orifices for controlled release of gliclazide solid dispersion system.
    Yang Y; Zhao Z; Wang Y; Yang L; Liu D; Yang X; Pan W
    Int J Pharm; 2016 Jun; 506(1-2):340-50. PubMed ID: 27132166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs.
    Efentakis M; Naseef H; Vlachou M
    Drug Dev Ind Pharm; 2010 Aug; 36(8):903-16. PubMed ID: 20196641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug release from liquisolid systems: speed it up, slow it down.
    Nokhodchi A; Hentzschel CM; Leopold CS
    Expert Opin Drug Deliv; 2011 Feb; 8(2):191-205. PubMed ID: 21222556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the use of novel drug delivery systems for antiretroviral drugs.
    Ojewole E; Mackraj I; Naidoo P; Govender T
    Eur J Pharm Biopharm; 2008 Nov; 70(3):697-710. PubMed ID: 18655830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in ocular drug delivery.
    Achouri D; Alhanout K; Piccerelle P; Andrieu V
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of hot-melt extrusion technology for designing an elementary osmotic pump system combined with solid dispersion for a novel poorly water-soluble antidepressant.
    Zhang X; Wang M; Li P; Wang A; Liang R; Gai Y; Liu W; Li Y; Sun K
    Pharm Dev Technol; 2016 Dec; 21(8):1006-1014. PubMed ID: 26446857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquisolid Technology: A State-of-the-Art Review on the Current State, Challenges, New and Emerging Technologies for Next Generation.
    Agiba AM
    Curr Drug Deliv; 2020; 17(9):736-754. PubMed ID: 32729418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug delivery systems with modified release for systemic and biophase bioavailability.
    Leucuta SE
    Curr Clin Pharmacol; 2012 Nov; 7(4):282-317. PubMed ID: 22794159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osmotically controlled drug delivery system with associated drugs.
    Gupta BP; Thakur N; Jain NP; Banweer J; Jain S
    J Pharm Pharm Sci; 2010; 13(4):571-88. PubMed ID: 21486532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered therapeutic proteins for sustained-release drug delivery systems.
    Nguyen TTK; Pham KY; Yook S
    Acta Biomater; 2023 Nov; 171():131-154. PubMed ID: 37717712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Research and application of quercetin-loaded nano drug delivery system].
    Li SJ; Liao YF; Du Q
    Zhongguo Zhong Yao Za Zhi; 2018 May; 43(10):1978-1984. PubMed ID: 29933659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in nasal drug delivery systems.
    Laffleur F; Bauer B
    Int J Pharm; 2021 Sep; 607():120994. PubMed ID: 34390810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanocrystals Technology for Transdermal Delivery of Water-Insoluble Drugs.
    Liu Y; Zhao J; Wang L; Yan B; Gu Y; Chang P; Wang Y
    Curr Drug Deliv; 2018; 15(9):1221-1229. PubMed ID: 29779482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Issues in contemporary drug delivery. Part VI: Advanced cardiac drug formulations.
    Hilleman DE; Banakar UV
    J Pharm Technol; 1992; 8(5):203-11. PubMed ID: 10121014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of a push-pull osmotic pump of felodipine solubilized by mesoporous silica nanoparticles with a core-shell structure.
    Wu C; Zhao Z; Zhao Y; Hao Y; Liu Y; Liu C
    Int J Pharm; 2014 Nov; 475(1-2):298-305. PubMed ID: 25148731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral bioavailability of silymarin formulated as a novel 3-day delivery system based on porous silica nanoparticles.
    Cao X; Fu M; Wang L; Liu H; Deng W; Qu R; Su W; Wei Y; Xu X; Yu J
    Acta Biomater; 2012 Jul; 8(6):2104-12. PubMed ID: 22343518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.